Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026)

Tilray Brands (TLRY) posted Cash from Investing Activities of $28.9 million for Q1 2026, up 149.85% on a QoQ basis from -$58.0 million in Q4 2025, and up 24400.0% year-over-year from N/an in Q1 2025.

Tilray Brands (TLRY) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Tilray Brands' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $28.9 million for Q1 2026.

  • Quarterly Cash from Investing Activities rose 24400.0% year-over-year to $28.9 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $8.9 million (up 158.62% YoY) and the FY2025 annual result came in at -$46.7 million, down 136.4% from the prior year.
  • Cash from Investing Activities was $28.9 million for Q1 2026 at Tilray Brands, up from -$58.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $81.5 million in Q4 2023 and bottomed at -$271.4 million in Q4 2022.
  • A 5-year average of -$12.6 million and a median of -$1.5 million in 2022 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Investing Activities slumped 3792.69% — and 2026, when it soared 24400.0%.
  • Tilray Brands' Cash from Investing Activities stood at -$271.4 million in 2022, then jumped by 130.03% to $81.5 million in 2023, then sank by 113.16% to -$10.7 million in 2024, then sank by 440.84% to -$58.0 million in 2025, then soared by 149.85% to $28.9 million in 2026.
  • Business Quant data shows TLRY's Cash from Investing Activities at $28.9 million in Q1 2026, -$58.0 million in Q4 2025, and $24.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.60 Bn 87.73 Bn - -
2 Teva Pharmaceutical Industries 35.91 Bn 32.16 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.46 Bn 30.52 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.13 Bn 20.98 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.75 Bn 16.43 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.60 Bn 12.18 Bn 785.00 Mn -60.00 Mn
10 Tilray Brands 452.95 Mn 392.75 Mn 54.95 Mn 28.92 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 28.92 Mn
Feb 28, 2026 28.92 Mn
Nov 30, 2025 -58.01 Mn
Nov 30, 2025 -58.01 Mn
Aug 31, 2025 24.47 Mn
Aug 31, 2025 24.47 Mn
May 31, 2025 13.52 Mn
May 31, 2025 13.52 Mn
Feb 28, 2025 -119,000.00
Feb 28, 2025 -119,000.00
Nov 30, 2024 -10.73 Mn
Nov 30, 2024 -10.73 Mn
Aug 31, 2024 -49.40 Mn
Aug 31, 2024 -49.40 Mn
May 31, 2024 45.06 Mn
May 31, 2024 45.06 Mn
Feb 29, 2024 28.09 Mn
Feb 29, 2024 28.09 Mn
Nov 30, 2023 81.50 Mn
Nov 30, 2023 81.50 Mn